SGS’ Life Science Services has 30 years of experience as a global CRO providing integrated solutions from preclinical activities to Phase I-IV trials, and bioanalytical and QC testing. We serve the pharmaceutical, biotechnology and medical device industries with over 1, 300 employees and 2,000 trials performed.

SGS can significantly improve client’s drug development timelines and decision-making processes  through innovative study designs, optimal facilities, and strong regulatory intelligence.

Taking a drug candidate from preclinical studies through an entire clinical drug development program requires an enormous commitment of resources and bears a number of challenges.

Clinical Research Facilities:

• Phase I units with a total of 162 beds
• Bioanalytical labs
• Phase II-IV clinical trial management offices across Europe, North America and Asia

Learn more about the Clinical Trials Services we offer.